Acquisition of a multidrug-resistant phenotype with a proteasome inhibitor in multiple myeloma

被引：41
作者：
Gutman, D. [1 ]
Morales, A. A.
Boise, L. H.
机构：
[1] Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, Miami, FL 33136 USA
来源：
LEUKEMIA | 2009年 / 23卷 / 11期
关键词：
IRREVERSIBLE INHIBITOR; INDUCE; CANCER;
D O I：
10.1038/leu.2009.123
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：2181 / 2183
页数：4
相关论文
共 8 条
  • [1] The proteasome: a novel target for cancer chemotherapy
    Almond, JB
    Cohen, GM
    [J]. LEUKEMIA, 2002, 16 (04) : 433 - 443
  • [2] Antitumor activity of PR-171, a novel irreversible inhibitor of the proteasome
    Demo, Susan D.
    Kirk, Christopher J.
    Aujay, Monette A.
    Buchholz, Tonia J.
    Dajee, Maya
    Ho, Mark N.
    Jiang, Jing
    Laidig, Guy J.
    Lewis, Evan R.
    Parlati, Francesco
    Shenk, Kevin D.
    Smyth, Mark S.
    Sun, Congcong M.
    Vallone, Marcy K.
    Woo, Tina M.
    Molineaux, Christopher J.
    Bennett, Mark K.
    [J]. CANCER RESEARCH, 2007, 67 (13) : 6383 - 6391
  • [3] Phase III study of PSC-833 (Valspodar) in combination with vincristine, doxorubicin, and dexamethasone (Valspodar/VAD) versus VAD alone in patients with recurring or refractory multiple myeloma (E1A95) - A Trial of the Eastern Cooperative Oncology Group
    Friedenberg, WR
    Rue, M
    Blood, EA
    Dalton, WS
    Shustik, C
    Larson, RA
    Sonneveld, P
    Greipp, PR
    [J]. CANCER, 2006, 106 (04) : 830 - 838
  • [4] Potent activity of carfilzomib, a novel, irreversible inhibitor of the ubiquitin-proteasome pathway, against preclinical models of multiple myelorna
    Kuhn, Deborah J.
    Chen, Qing
    Voorhees, Peter M.
    Strader, John S.
    Shenk, Kevin D.
    Sun, Congcong M.
    Derno, Susan D.
    Bennett, Mark K.
    Van Leeuwen, Fijs W. B.
    Chanan-Khan, Asher A.
    Orlowski, Robert Z.
    [J]. BLOOD, 2007, 110 (09) : 3281 - 3290
  • [5] Treatment of multiple myeloma: An emphasis on new developments
    Kyle, RA
    Rajkumar, SV
    [J]. ANNALS OF MEDICINE, 2006, 38 (02) : 111 - 115
  • [6] Mechanisms of proteasome inhibitor action and resistance in cancer
    McConkey, David J.
    Zhu, Keyi
    [J]. DRUG RESISTANCE UPDATES, 2008, 11 (4-5) : 164 - 179
  • [7] Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells
    Obeng, Esther A.
    Carlson, Louise M.
    Gutman, Delia M.
    Harrington, William J., Jr.
    Lee, Kelvin P.
    Boise, Lawrence H.
    [J]. BLOOD, 2006, 107 (12) : 4907 - 4916
  • [8] Overcoming drug resistance in multiple myeloma: The emergence of therapeutic approaches to induce apoptosis
    Yang, HH
    Ma, MH
    Vescio, RA
    Berenson, JR
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (22) : 4239 - 4247
1